Heron Therapeutics (NASDAQ:HRTX) specializes in developing innovative treatments aimed at addressing unmet medical needs in pain management and oncology. Their portfolio includes advanced therapeutics designed to improve the lives of patients undergoing surgery or those facing challenging cancer treatments. Heron is dedicated to pushing the boundaries of science to create solutions that can significantly enhance patient care and outcomes. Their objectives focus on advancing their research and development pipeline, ensuring the accessibility of their therapies, and maintaining a strong commitment to ethical practices and sustainability in all their operations.